Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $49.4450 (4.05%) ($49.4450 - $49.4800) on Fri. Jan. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.21% (three month average) | RSI | 42 | Latest Price | $49.4450(4.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.7% a day on average for past five trading days. | Weekly Trend | TGTX declines -2.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(66%) ARKG(63%) ARKK(59%) IBB(58%) IWO(58%) | Factors Impacting TGTX price | TGTX will decline at least -3.105% in a week (0% probabilities). VIXM(-41%) VXX(-36%) UUP(-19%) UNG(-3%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.105% (StdDev 6.21%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $44.55(-9.9%) | Inflection Point | Yes | Resistance Level | $51.57 | 5 Day Moving Average | $49.39(0.11%) | 10 Day Moving Average | $50.86(-2.78%) | 20 Day Moving Average | $51.57(-4.12%) | To recent high | -9.7% | To recent low | 96.1% | Market Cap | $6.262b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |